IE36854B1 - Anaesthetic compositions - Google Patents

Anaesthetic compositions

Info

Publication number
IE36854B1
IE36854B1 IE1597/71A IE159771A IE36854B1 IE 36854 B1 IE36854 B1 IE 36854B1 IE 1597/71 A IE1597/71 A IE 1597/71A IE 159771 A IE159771 A IE 159771A IE 36854 B1 IE36854 B1 IE 36854B1
Authority
IE
Ireland
Prior art keywords
pregnane
dione
solution
recovered
hydroxy
Prior art date
Application number
IE1597/71A
Other languages
English (en)
Other versions
IE36854L (en
Original Assignee
Glaxo Lab Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Lab Ltd filed Critical Glaxo Lab Ltd
Publication of IE36854L publication Critical patent/IE36854L/xx
Publication of IE36854B1 publication Critical patent/IE36854B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/005—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 the 17-beta position being substituted by an uninterrupted chain of only two carbon atoms, e.g. pregnane derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
    • C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
    • C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
    • C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
    • C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Biophysics (AREA)
  • Steroid Compounds (AREA)
IE1597/71A 1970-12-17 1971-12-16 Anaesthetic compositions IE36854B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB6006970A GB1380247A (en) 1970-12-17 1970-12-17 Anaesthetic compositions

Publications (2)

Publication Number Publication Date
IE36854L IE36854L (en) 1972-06-17
IE36854B1 true IE36854B1 (en) 1977-03-16

Family

ID=10484953

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1597/71A IE36854B1 (en) 1970-12-17 1971-12-16 Anaesthetic compositions

Country Status (9)

Country Link
AU (1) AU473308B2 (fr)
BE (1) BE776790A (fr)
CA (1) CA975682A (fr)
DE (1) DE2162591A1 (fr)
FR (1) FR2118122B1 (fr)
GB (1) GB1380247A (fr)
IE (1) IE36854B1 (fr)
NL (1) NL7117309A (fr)
ZA (1) ZA718467B (fr)

Also Published As

Publication number Publication date
CA975682A (en) 1975-10-07
AU473308B2 (en) 1976-06-17
FR2118122A1 (fr) 1972-07-28
DE2162591A1 (de) 1972-07-06
IE36854L (en) 1972-06-17
AU3696371A (en) 1973-06-21
GB1380247A (en) 1975-01-08
NL7117309A (fr) 1972-06-20
FR2118122B1 (fr) 1975-12-26
BE776790A (fr) 1972-06-16
ZA718467B (en) 1973-08-29

Similar Documents

Publication Publication Date Title
GB1429922A (en) Steroid acetals processes for their manufacture and preparations containing them
NL7701427A (nl) Werkwijze voor de scheiding van stoffen door gefractioneerde kristallisatie uit een vloei- baar mengsel.
US2773080A (en) delta-pregnenes
NL7501765A (nl) Werkwijze voor het winnen van technisch zuiver azijnzuur door een extractieve destillatie.
NL277685A (nl) Werkwijze voor de gelijktijdige winning van zuiver ammoniumsulfaat en zuvere lactamen uit omzettingsmengsels val alicyclische ketoximen
US2865935A (en) 2-methyl steroids and process
CA1015143A (en) Method of attaching resilient liners to steel structures
AU7072774A (en) Process for recovery of e-caprolactam from a reaction mixture of e-caprolactam and sulphuric acid
IE36854L (en) Anaesthetic
YU340774A (en) Process for the isolation of crude lead from sulfidic
US2867631A (en) 6-methylated and 11-oxygenated-17 alpha-hydroxy-21-fluoro 4-pregnene 3, 20 diones
AU484156B2 (en) Process forthe separation of diene from organic mixtures
IE40163L (en) Pharmaceutical compositions containing steroids
US2708672A (en) 11beta, 17alpha-dihydroxypregnane-3, 20-dione and process
US3019244A (en) 11alpha-allylated 11beta-hydroxy-5beta-pregnane-3, 20-dione bisoximes and process
US3364241A (en) Process for the production of 6alpha-fluoro-16alpha-halo pregnanes and the intermediates therefor
BE778942A (fr) Procede de separation des constituants d'un melange de polyisocyanates organiques
US2808415A (en) Delta4, 8(9)-3, 20-diketo-11, 17-dihydroxy-21-oxygenated-pregnadienes and processes of preparing the same
US3054812A (en) 20beta, 21-dinitrato-delta4-pregnene-17alpha-ol-3, 11-dione, its production, and method of use
GB1444154A (en) 15alpha, 16alpha-delta4-pregnenes
ES378040A1 (es) Procedimiento para la fabricacion de acido borico.
US3463775A (en) 17alpha-methyl-retrosteroids
ES264322A1 (es) Un procedimiento de preparaciƫn de nuevos compuestos esteroides nitrogenados
CA959071A (en) Process for the separation and recovery of methylterephthalic acid and 4-methylisophthalic acid from a mixture thereof
US3080391A (en) 6alpha-chloro-delta1, 4-androstadien-17beta-ol-3-one derivatives